Physician profile
Patrick W Kelly
NPI 1134189160
$13,812.57
in general payments reported to CMS, 2019-2025
39 companies · $4,744 in 2025
The $4,744 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $2,469 · 2021: $2,748 · 2022: $980 · 2023: $1,114 · 2024: $414 · 2025: $4,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,246 · Travel and Lodging: $3,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,246.28 |
| Travel and Lodging | $3,025.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $3,862.23 | 2021-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $2,651.64 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic Vascular, INC. | $2,528.65 | 2019-2020 | |
| Medtronic, INC. | $1,906.57 | 2021-2025 | Mo.Ma Ultra, Concertotm, Endurant Iis |
| Lemaitre Vascular, INC. | $613.46 | 2021-2024 | Restoreflow, Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $349.21 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $263.79 | 2022-2025 | Jetstream Sc |
| Reflow Medical INC | $146.47 | 2025 | |
| Atrium Medical Corporation | $128.77 | 2020 | |
| Janssen Pharmaceuticals, INC | $114.19 | 2022-2024 | Xarelto |
| Terumo Medical Corporation | $112.23 | 2022 | |
| Tactile Systems Technology INC | $104.35 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Organogenesis INC. | $100.71 | 2023-2025 | Puraply, Nushield |
| Argon Medical Devices, INC. | $95.84 | 2022-2025 | Skater, Clot Management, Retrieval Kit |
| Abbott Laboratories | $77.34 | 2023-2025 | Esprit, Perclose Prostyle, Jeti Peripheral Catheter |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $77.04 | 2019-2024 | Grafix |
| Penumbra, INC. | $73.40 | 2019 | |
| Abiomed | $62.25 | 2024 | Impella |
| Getinge USA Sales, LLC | $51.08 | 2020 | |
| Silk Road Medical, INC. | $49.35 | 2021 | |
| Angiodynamics, INC. | $45.10 | 2022 | |
| Asahi Intecc USA, INC. | $42.48 | 2024 | Peripheral Vascular |
| Molnlycke Health Care US, LLC | $36.72 | 2022-2023 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mextra Superabsorbant |
| Mimedx Group, INC. | $33.03 | 2024-2025 | |
| Cardiva Medical, INC. | $26.77 | 2023 | Cardiva Vascade 6/7f Vcs |
| Kerecis Limited | $26.35 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Reprise Biomedical, INC. | $25.48 | 2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $23.86 | 2025 | Topical Oxygen Chamber For Extremities |
| E.R. Squibb & Sons, L.L.C. | $23.85 | 2022 | |
| Admedus Corporation | $21.89 | 2019 | |
| Becton, Dickinson and Company | $21.53 | 2025 | Lifestream |
| Melinta Therapeutics, LLC | $21.27 | 2022 | |
| Philips North America LLC | $20.57 | 2023 | |
| Integra Lifesciences Corporation | $16.77 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $16.00 | 2023 | Stratafix |
| Solventum Corporation | $15.79 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Chiesi USA, INC. | $13.87 | 2023 | Cleviprex |
| Kci USA, INC. | $12.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.